CS
ARVN icon

Candriam SCA’s Arvinas ARVN Stock Holding History

Candriam SCA’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-503,936
Closed -$9.66M – 679
2024
Q4 		$9.66M Sell
503,936
-20,845
-4% -$506K 0.06% 264
2024
Q3 		$12.9M Sell
524,781
-85,677
-14% -$2.24M 0.07% 237
2024
Q2 		$16.2M Buy
610,458
+147,904
+32% +$4.71M 0.1% 205
2024
Q1 		$19.1M Sell
462,554
-25,001
-5% -$1.09M 0.12% 172
2023
Q4 		$20.1M Buy
487,555
+40,004
+9% +$935K 0.14% 159
2023
Q3 		$8.79M Sell
447,551
-20,002
-4% -$491K 0.06% 241
2023
Q2 		$11.6M Sell
467,553
-27,394
-6% -$705K 0.08% 229
2023
Q1 		$12.4M Sell
494,947
-39,055
-7% -$1.23M 0.09% 228
2022
Q4 		$18.3M Buy
534,002
+14,710
+3% +$619K 0.12% 181
2022
Q3 		$23.1M Buy
519,292
+22,345
+4% +$1.08M 0.16% 143
2022
Q2 		$20.9M Buy
496,947
+6,240
+1% +$313K 0.17% 132
2022
Q1 		$33M Sell
490,707
-31,599
-6% -$2.15M 0.22% 104
2021
Q4 		$42.9M Buy
522,306
+176,712
+51% +$14.4M 0.27% 93
2021
Q3 		$28.4M Buy
345,594
+94,991
+38% +$8.4M 0.19% 125
2021
Q2 		$19.3M Sell
250,603
-38,811
-13% -$2.69M 0.13% 182
2021
Q1 		$23.6M Hold
289,414
– – 0.2% 131
2020
Q4 		$24.6M Sell
289,414
-31,552
-10% -$1.09M 0.19% 132
2020
Q3 		$7.58M Sell
320,966
-43,319
-12% -$1.26M 0.07% 277
2020
Q2 		$12.2M Buy
364,285
+91,462
+34% +$3.88M 0.13% 185
2020
Q1 		$11M Buy
272,823
+17
+0% +$795 0.12% 196
2019
Q4 		$11.2M Buy
272,806
+27,015
+11% +$791K 0.12% 198
2019
Q3 		$5.3M Buy
+245,791
New +$6.03M 0.07% 304

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Candriam SCA's ARVN Position: Q1 2025 in Review

Candriam SCA sold out of Arvinas (ARVN) in Q1 2025, closing a stake of 503,936 shares — an estimated $9.66M sold.

Candriam SCA first reported a position in ARVN in Q3 2019 and held it in 22 quarters. The position peaked at $42.9M in Q4 2021. 215 funds tracked by Wall St. Rank hold ARVN as of Q1 2025.

  • Candriam SCA reported no remaining Arvinas position as of Q1 2025 after selling out during the quarter.
  • Candriam SCA sold 503,936 Arvinas shares in Q1 2025, an estimated $9.66M.
  • Candriam SCA first reported a position in Arvinas in Q3 2019 and held it in 22 quarters.
  • Candriam SCA's Arvinas position peaked at $42.9M in Q4 2021.
  • 215 funds tracked by Wall St. Rank held Arvinas as of Q1 2025.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.